Want to join the conversation?
$FLO updated the guidance for its Accelerated Stock Repurchase agreement for FY16. $FLO now expects sales in the range of $3.986-4.080Bil, representing growth of approx. 5.5-8.0% YoverY. EPS is expected in the range of $1.00-1.06, including approx. $0.02 of accretion from the ASR, representing growth of approx. 8.7-15.2% YoverY.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?